Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcome

Alcohol and Alcoholism

Volumn 36, Issue 2, 2001, Pages 109-111

  Mattick, R P ^a   Ali, R ^a   Auriacombe, M ^a   Davoli, M ^a   Faggiano, F ^a   Farrell, M ^a   Ferri, M ^a   Ling, W ^a  

^a Agenzia di Sanita Pubblica della Regione Lazio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BUPRENORPHINE; CARBAMAZEPINE; COCAINE; DRUG; NALTREXONE; OPIATE; OPIATE ANTAGONIST;

ALCOHOLISM; AUSTRIA; CLINICAL PRACTICE; CLINICAL PROTOCOL; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FRANCE; HEALTH CARE; HUMAN; ITALY; NOTE; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; REGISTER; TREATMENT OUTCOME; UNITED KINGDOM; UNITED STATES;

ALCOHOLISM; DATABASES, FACTUAL; HUMANS; PEER REVIEW; TREATMENT OUTCOME;

EID: 0035067262     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/36.2.109     Document Type: Note

References (11)

1. LAAM maintenance vs methadone maintenance for heroin dependence
2. Methadone maintenance at different dosages for opioid dependence (Protocol for a Chochrane Review)
3. Buprenorphine for the management of opioid dependence
4. Opioid antagonists and adrenergic agonists for the management of opioid dependence
5. Opioid antagonists under sedation or anaesthesia for opioid withdrawal
6. Alpha2 adrenergic agonists for the management of opioid withdrawal
7. Naltrexone maintenance treatment for opioid dependence
8. Carbamazepine for cocaine dependence
9. Methadone maintenance versus no methadone maintenance for opioid dependence
10. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
11. Opioid antagonists for alcohol dependence